国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Methylococcus capsulatus UPF0271 protein MCA0476 (MCA0476) CSB-YP726705MFM
CSB-EP726705MFM
CSB-BP726705MFM
CSB-MP726705MFM
CSB-EP726705MFM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylococcus capsulatus Ribosome maturation factor RimM (rimM) CSB-YP726706MFM
CSB-EP726706MFM
CSB-BP726706MFM
CSB-MP726706MFM
CSB-EP726706MFM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylococcus capsulatus Protein RecA (recA) CSB-YP726707MFM
CSB-EP726707MFM
CSB-BP726707MFM
CSB-MP726707MFM
CSB-EP726707MFM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylococcus capsulatus Ribose-5-phosphate isomerase A (rpiA) CSB-YP726708MFM
CSB-EP726708MFM
CSB-BP726708MFM
CSB-MP726708MFM
CSB-EP726708MFM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylococcus capsulatus 3-dehydroquinate synthase (aroB) CSB-YP726709MFM
CSB-EP726709MFM
CSB-BP726709MFM
CSB-MP726709MFM
CSB-EP726709MFM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylococcus capsulatus Iron-sulfur cluster insertion protein ErpA 1 (erpA1) CSB-YP726710MFM
CSB-EP726710MFM
CSB-BP726710MFM
CSB-MP726710MFM
CSB-EP726710MFM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylococcus capsulatus Bis (5'-nucleosyl)-tetraphosphatase, symmetrical (apaH) CSB-YP726711MFM
CSB-EP726711MFM
CSB-BP726711MFM
CSB-MP726711MFM
CSB-EP726711MFM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylococcus capsulatus Octanoyltransferase (lipB) CSB-YP726712MFM
CSB-EP726712MFM
CSB-BP726712MFM
CSB-MP726712MFM
CSB-EP726712MFM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylococcus capsulatus Protoheme IX farnesyltransferase (cyoE), partial CSB-YP726713MFM
CSB-EP726713MFM
CSB-BP726713MFM
CSB-MP726713MFM
CSB-EP726713MFM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylococcus capsulatus ATP synthase subunit delta (atpH) CSB-YP726714MFM
CSB-EP726714MFM
CSB-BP726714MFM
CSB-MP726714MFM
CSB-EP726714MFM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylococcus capsulatus Glycine cleavage system H protein (gcvH) CSB-YP726715MFM
CSB-EP726715MFM
CSB-BP726715MFM
CSB-MP726715MFM
CSB-EP726715MFM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Serine/threonine-protein kinase Nek4 (NEK4), partial CSB-YP726716OFG
CSB-EP726716OFG
CSB-BP726716OFG
CSB-MP726716OFG
CSB-EP726716OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica CBL-interacting protein kinase 20 (CIPK20) CSB-YP726717OFG
CSB-EP726717OFG
CSB-BP726717OFG
CSB-MP726717OFG
CSB-EP726717OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfate adenylyltransferase (atps) CSB-YP726718EXX
CSB-EP726718EXX
CSB-BP726718EXX
CSB-MP726718EXX
CSB-EP726718EXX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cat Growth arrest and DNA damage-inducible protein GADD45 alpha (GADD45A) CSB-YP726719CA
CSB-EP726719CA
CSB-BP726719CA
CSB-MP726719CA
CSB-EP726719CA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial (NDUFS8) CSB-YP726720MOV
CSB-EP726720MOV
CSB-BP726720MOV
CSB-MP726720MOV
CSB-EP726720MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Carnitine O-palmitoyltransferase 2, mitochondrial (CPT2), partial CSB-YP726721MOV
CSB-EP726721MOV
CSB-BP726721MOV
CSB-MP726721MOV
CSB-EP726721MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ankyrin repeat and KH domain-containing protein CBG24701 (CBG24701), partial CSB-YP726722CXX
CSB-EP726722CXX
CSB-BP726722CXX
CSB-MP726722CXX
CSB-EP726722CXX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable elongator complex protein 3 (elpc-3), partial CSB-YP726723CXX
CSB-EP726723CXX
CSB-BP726723CXX
CSB-MP726723CXX
CSB-EP726723CXX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Degenerin mec-10 (mec-10), partial CSB-YP726724CXX
CSB-EP726724CXX
CSB-BP726724CXX
CSB-MP726724CXX
CSB-EP726724CXX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>